Safety and efficacy of low-molecular-weight heparin in pregnant women at risk of venous thromboembolism: Prospective cohort study - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Safety and efficacy of low-molecular-weight heparin in pregnant women at risk of venous thromboembolism: Prospective cohort study

Authors list: Bauersachs, RM; Dudenhausen, J; Faridi, A; Fischer, T; Fung, S; Geisen, U; Harenberg, J; Herchenhan, E; Keller, F; Kemkes-Matthes, B; Schinzel, H; Spannagl, M; Thaler, CJ

Publication year: 2005

Pages: 149-149

Journal: Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis

Volume number: 115

ISSN: 0049-3848

Conference: International Symposium on Womens Health Issues in Thrombosis and Hemostasis

Publisher: Elsevier

Citation Styles

Harvard Citation style: Bauersachs, R., Dudenhausen, J., Faridi, A., Fischer, T., Fung, S., Geisen, U., et al. (2005) Safety and efficacy of low-molecular-weight heparin in pregnant women at risk of venous thromboembolism: Prospective cohort study, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, 115, p. 149

APA Citation style: Bauersachs, R., Dudenhausen, J., Faridi, A., Fischer, T., Fung, S., Geisen, U., Harenberg, J., Herchenhan, E., Keller, F., Kemkes-Matthes, B., Schinzel, H., Spannagl, M., & Thaler, C. (2005). Safety and efficacy of low-molecular-weight heparin in pregnant women at risk of venous thromboembolism: Prospective cohort study. Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis. 115, 149.

SDG Areas